• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Legal & General Global Health & Pharmaceuticals Index Trust (C) - Accumulation (Restricted Fund)

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Legal & General(Unit Trust Managers)Ltd
Fund Summary The objective of this fund is to provide growth by tracking the performance of those companies in the FTSE World Index which are engaged in Health, Pharmaceuticals and Biotechnology activities.The fund will invest almost entirely in company shares. The fund's investments will closely match those that make up the Index. The Index consists of company shares from around the world.The fund may use derivatives (contracts which have a value linked to the price of another asset) for the following purposes:™To help with efficient day to day management.™To reduce some of the risks of the market.If you hold accumulation units, income from investments held by the fund (dividends) will be reinvested into the value of your units.If you hold distribution units, income from investments held by the fund will be paid out to you (as a dividend).This fund may not be appropriate for investors who plan to withdraw their money within five years.
Fund code LGHCA
Managers Not Disclosed
Manager Tenure 7 years
Morningstar Category Sector Equity Healthcare
IMA Sector Global
Fund Size £602 million
Fund Type OEIC
Management Style Passive
Ongoing Charge Figure (OCF) 0.2%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.0062
Buy Price £0.0062
Price Date 8th July 2020
Yield 1.30%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 28th May 2019
Fund Status OPEN

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2019
Fund Performance +16.71%
Benchmark Performance
(Sector Equity Healthcare)
Time Period Cumulative Benchmark Performance
(Sector Equity Healthcare)
Fund Compared to Benchmark
1 day -0.21% +12.80% -13.01%
1 week 0.43% +3.52% -3.09%
1 month 1.54% +17.22% -15.67%
3 months 12.89% +11.96% +0.93%
6 months 7.83% +16.92% -9.09%
1 year 15.14% +17.01% -1.86%
3 years Currently unavailable Currently unavailable Currently unavailable
5 years Currently unavailable Currently unavailable Currently unavailable
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 8.60% +0.85% +7.75%
Since inception 15.75% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Johnson & Johnson USA 6.84%
UnitedHealth Group Inc USA 5.01%
Roche Holding AG Dividend Right Cert. CHE 4.28%
Pfizer Inc USA 3.70%
Merck & Co Inc USA 3.53%
Novartis AG CHE 3.23%
AbbVie Inc USA 2.81%
Abbott Laboratories USA 2.79%
AstraZeneca PLC GBR 2.50%
Bristol-Myers Squibb Company USA 2.46%

Currently unavailable